Richard “Rick” Slayman, the first person to receive a genetically modified pig kidney transplant, has passed away nearly two months after undergoing the groundbreaking procedure.
Slayman, 62, who suffered from end-stage kidney disease, received the transplant in March at Massachusetts General Hospital in Boston.
The hospital confirmed on Saturday that Slayman’s death was unrelated to the transplant, emphasizing that there was “no indication” that the procedure led to his passing. The transplant surgeon had expressed hope that the kidney would function for at least two years.
In a statement released by the hospital, the transplant team mourned Slayman’s sudden demise, hailing him as a symbol of hope for transplant patients worldwide. The surgery marked a significant milestone in xenotransplantation — the transfer of organs from one species to another — aiming to address the organ shortage crisis for individuals in need of transplants.
Slayman’s family expressed gratitude to his doctors, acknowledging their tireless efforts in advancing xenotransplantation. Describing Slayman as kind, quick-witted, and deeply devoted to his loved ones, the family highlighted his desire to inspire hope for those awaiting transplants.
Following his transplant, Slayman had expressed a desire to provide hope for thousands of transplant patients. His family affirmed that his legacy of hope and optimism would endure, serving as a beacon for others in need of organ transplants.
Last month, a 54-year-old woman from New Jersey became the second individual to undergo a genetically modified pig kidney transplant.
With over 100,000 people on the organ transplant waitlist in the U.S. and thousands passing away annually before receiving a transplant, Slayman’s journey underscored the urgent need for innovative solutions to address the organ shortage crisis.
